Israel - hebraisk - Ministry of Health

alexion pharma israel ltd - ravulizumab - תרכיז להכנת תמיסה לאינפוזיה - ravulizumab 10 mg/ml - ravulizumab

Israel - hebraisk - Ministry of Health

alexion pharma israel ltd - ravulizumab - תרכיז להכנת תמיסה לאינפוזיה - ravulizumab 100 mg/ml - ravulizumab

Israel - hebraisk - Ministry of Health

j-c health care ltd - ustekinumab - תמיסה להזרקה - ustekinumab 45 mg / 0.5 ml - ustekinumab - ustekinumab - stelara™ is indicated for the treatment of moderate to severe plaque psoriasis in adult patients (18 years or older) who have failed to,or have contraindication to or who are intolerant to other systemic therapies including ciclosporin,methotrexate and psoralen plus u.v (puva).

Israel - hebraisk - Ministry of Health

j-c health care ltd - ustekinumab - תמיסה להזרקה - ustekinumab 45 mg / 0.5 ml - ustekinumab - ustekinumab - stelara is indicated for the treatment of moderate to severe plaque psoriasis in adult patients (18 years or older) who have failed to, or have contraindication to or who are intolerant to other systemic therapies including ciclosporin, methotrexate and psoralen plus u.v (puva).

Israel - hebraisk - Ministry of Health

j-c health care ltd - ustekinumab - תרכיז להכנת תמיסה לאינפוזיה - ustekinumab 5 mg / 1 ml - ustekinumab

Israel - hebraisk - Ministry of Health

j-c health care ltd - ustekinumab - תמיסה להזרקה - ustekinumab 45 mg / 0.5 ml - ustekinumab

Israel - hebraisk - Ministry of Health

glaxo smith kline (israel) ltd - mepolizumab - אבקה להכנת תמיסה לזריקה - mepolizumab 100 mg - mepolizumab

Israel - hebraisk - Ministry of Health

astrazeneca (israel) ltd - benralizumab - תמיסה להזרקה - benralizumab 30 mg / 1 ml - benralizumab

Israel - hebraisk - Ministry of Health

glaxo smith kline (israel) ltd - mepolizumab - תמיסה להזרקה - mepolizumab 100 mg / 1 ml - mepolizumab

Israel - hebraisk - Ministry of Health

astrazeneca (israel) ltd - tezepelumab - תמיסה להזרקה - tezepelumab 110 mg/ml - tezepelumab